Prostate cancer patients ditching treatment in favour of monitoring: Study - Starts at 60

Typically, active surveillance involves prostate-specific antigen (PSA) tests every three to six months, digital rectal examination every six months, mpMRI scans, and biopsies at 12 months and three years. If the cancer shows sign of faster or more aggressive growth, a patient can start treatment or undergo surgery.



https://ift.tt/2ElWNoD

Comments

Popular posts from this blog

Sentinel lymph node biopsy: What cancer patients should know

Q&A

What Type of Cancer Causes Low Hemoglobin (Anemia)?